Palo Alto Investors’s Sight Sciences SGHT Stock Holding History

Palo Alto Investors’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-173,790	Closed	-$897K	–	39
2023 Q4	$897K	Buy	+173,790	New	+$536K	0.08%	32

Other funds holding SGHT

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AMH

Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Palo Alto Investors's SGHT Position: Q1 2024 in Review

Palo Alto Investors sold out of Sight Sciences (SGHT) in Q1 2024, closing a stake of 173,790 shares — an estimated $897K sold.

Palo Alto Investors first reported a position in SGHT in Q4 2023 and held it in 1 quarter. The position peaked at $897K in Q4 2023. 65 funds tracked by Wall St. Rank hold SGHT as of Q1 2024.

Palo Alto Investors reported no remaining Sight Sciences position as of Q1 2024 after selling out during the quarter.
Palo Alto Investors sold 173,790 Sight Sciences shares in Q1 2024, an estimated $897K.
Palo Alto Investors first reported a position in Sight Sciences in Q4 2023 and held it in 1 quarter.
Palo Alto Investors's Sight Sciences position peaked at $897K in Q4 2023.
65 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2024.

Based on Palo Alto Investors's 13F filing for Q1 2024, filed 15 May 2024.